Exploring the Effects of Smoking Cessation Interventions for Asians and Asian Americans: A Meta-Analytic Review by Pham, Amber T.
DePaul University 
Via Sapientiae 
College of Science and Health Theses and 
Dissertations College of Science and Health 
Summer 8-22-2021 
Exploring the Effects of Smoking Cessation Interventions for 
Asians and Asian Americans: A Meta-Analytic Review 
Amber T. Pham 
DePaul University, apham10@depaul.edu 
Follow this and additional works at: https://via.library.depaul.edu/csh_etd 
 Part of the Psychology Commons 
Recommended Citation 
Pham, Amber T., "Exploring the Effects of Smoking Cessation Interventions for Asians and Asian 
Americans: A Meta-Analytic Review" (2021). College of Science and Health Theses and Dissertations. 
399. 
https://via.library.depaul.edu/csh_etd/399 
This Dissertation is brought to you for free and open access by the College of Science and Health at Via Sapientiae. 
It has been accepted for inclusion in College of Science and Health Theses and Dissertations by an authorized 
administrator of Via Sapientiae. For more information, please contact digitalservices@depaul.edu. 





Exploring the Effects of Smoking Cessation Interventions for Asians and Asian Americans: 
A Meta-Analytic Review 
 
A Dissertation  
Submitted in Partial Fulfillments of the Requirements for the Degree of  
Doctor of Philosophy in Clinical-Community Psychology 
Department of Psychology  





Amber T. Pham, M.A. 














Anne Saw, Ph.D. 
Chairperson 
Antonio Polo, Ph.D. 
Joanna Buscemi, Ph. D. 
Young Me-Lee, Ph.D. 






SMOKING CESSATION INTERVENTIONS FOR AAs iii 
Acknowledgments 
I would like to thank the following people for supporting me through the course of this 
project, as well as my graduate career. First, I would like to express my sincerest gratitude to my 
advisor, Dr. Anne Saw. Thank you for your patience and guidance in every step of this project. I 
cannot thank you enough for dedicating your time and effort to edit my dissertation amongst 
your many responsibilities. As a mentor, you always challenged me and I am a stronger graduate 
student and person for it. Thanks for believing in me and constantly pushing me to do my best.  
 Second, I would like to express my gratitude towards my dissertation committee. I 
appreciate your insightful comments and willingness to help me with my project. Thank you for 
reviewing my dissertation and offering suggestions to make it the best it can be.   
Third, I would like to thank all my wonderful friends for their support and motivation. I 
would not have survived without their encouragement throughout the process. Thank you for 
reminding me there is a light at the end of the tunnel and for making graduate school enjoyable.  
Fourth, I would like to thank my fiancé, Brian Lee. You have been with me every step of 
the way and continuously cheer me on as I run towards the finish line. You believed in me when 
I did not believe in myself. You have made graduate school the best years of my life. Thank you 
for your unconditional love and support.  
 Finally, I would like to thank my wonderful parents who supported me emotionally and 
financially from afar. You have sacrificed so much so that I could have a successful and happy 
future. You have raised me to be resilient, hard-working, and strong, and I am everything I am 
today because of you. Thank you for EVERYTHING! 
SMOKING CESSATION INTERVENTIONS FOR AAs iv 
VITA 
Amber Pham was born and raised in Fort Smith, Arkansas on January 16th, 1993. She attended 
the University of Arkansas, Fayetteville, majoring in Psychology and double minoring in 
Chinese and Social Work. She graduated in 2015 with a Bachelor of Arts. She then moved to 
Chicago, Illinois where she obtained her Master of Arts in Clinical Psychology from DePaul 
University. She is currently pursuing her doctoral degree and will begin her pre-doctoral 
internship at the Cincinnati VA Medical Center, with a specialization in neuropsychology, in 













SMOKING CESSATION INTERVENTIONS FOR AAs v 
Table of Contents 
ABSTRACT ....................................................................................................................................6 
INTRODUCTION..........................................................................................................................7 
SMOKING IN THE US .....................................................................................................................7 
SMOKING IN ASIA .........................................................................................................................7 
SMOKING-RELATED CONSEQUENCES AMONG ASIANS AND ASIAN AMERICANS ...........................8 
TOBACCO INTERVENTIONS  ...........................................................................................................9 
RATIONALE FOR SYSTEMATIC REVIEW AND META-ANALYSIS ...................................................12 
HYPOTHESES ...............................................................................................................................17 
METHOD .....................................................................................................................................18 
LITERATURE SEARCH ..................................................................................................................18 
INCLUSION CRITERIA ..................................................................................................................19 
EXCLUSION CRITERIA .................................................................................................................19 
ARTICLE SELECTION AND CODING PROCEDURES ........................................................................20 






SMOKING CESSATION INTERVENTION OUTCOMES      6 
Abstract 
Cigarette smoking continues to be a leading health problem in the United States and worldwide. 
Despite high prevalence rates among some subpopulations of Asians and Asian Americans, little 
attention has been focused on identifying effective smoking cessation interventions for this 
group. A meta-analysis examining effect sizes was conducted to test the hypothesis that smoking 
cessation interventions, overall, improve quit outcomes among Asians and Asian Americans. 
Factors associated with intervention effectiveness were explored through moderator analyses. 
Results show that overall, smoking cessation interventions are efficacious for Asians and Asian 
Americans (OR = 2.33). Moderator analyses revealed high intensity treatments and treatments 
with biochemical verification are associated with greater odds of cessation. Specific methods of 
cultural tailoring were not found to have a significant effect on smoking cessation outcomes. The 
present study has significant research, theoretical, and clinical implications for smoking 
cessation interventions targeting Asians and Asian Americans.  
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Exploring the Effectiveness of Smoking Cessation Interventions for Asians and Asian 
Americans: A Meta-Analytic Review 
Smoking remains a leading health problem in the United States. Although effective 
empirically supported treatments are available, disparities in smoking prevalence remain among 
different racial, ethnic, and cultural groups. However, little attention has been focused on 
smoking cessation among Asians and Asian Americans (AAs). The current systematic review 
and meta-analysis examined: 1) the effectiveness of smoking cessation interventions for AAs; 2) 
whether culturally tailored smoking cessation interventions are more effective than non-
culturally tailored smoking cessation interventions; and 3) moderating variables that strengthen 
outcomes. 
Smoking in the United States 
 In 2014, the Centers for Disease Control and Prevention (CDC) reported cigarette 
smoking as the leading cause of preventable disease and death in the United States. In 2016, 37.8 
million people identified as smokers in the United States; about 480,000 of these smokers will 
die of smoking-related health problems (CDC, 2018; U.S. Department of Health and Human 
Services (HHS), 2014). Mortality is three times higher for smokers than nonsmokers (HHS, 
2014), and tobacco smoking is expected to lead to 450 million deaths worldwide in the next 50 
years (CDC, 2005). Smoking is associated with many health consequences, such as increased 
risk for cancer, chronic obstructive pulmonary disease (COPD), strokes, diabetes, and heart 
disease (HHS, 2014).  
Smoking in Asia 
Male smoking prevalence in individual Asian countries is considerably higher than in the 
United States (Benowitz et al., 1998). The breakdown of adult male current smoking rates for a 
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few countries from 2016 are as follows: Korea (39.3%), Vietnam (45.3%), Philippines (40.3%), 
Indonesia (64.9%), Laos (50.8%), Thailand (40.5%), India (24.3%), Tonga (42.1%) and China 
(52.1%) (World Health Organization (WHO), 2017). China is the largest tobacco producer and 
consumer in the world (WHO, 2013). In 2016, China and India had the highest death rates in the 
world related to tobacco smoking and secondhand smoke exposure (Ritchie & Roser, 2018).  
Smoking-Related Consequences among AAs 
Although heart disease is the leading cause of death in the United States, lung and 
bronchus cancer are the leading cause of death for AAs (Heron, 2007). Unhealthy behaviors like 
smoking can contribute to cancer-related disparities. National studies estimate that AAs have the 
lowest prevalence of smoking among major ethnic groups in the United States (Substance Abuse 
and Mental Health Services Administration (SAMHSA), 2015). Current past-month cigarette 
smoking rates for major ethnic groups in the United Sates are as follows: Asian Americans 
(8.9%), Native Hawaiian/Pacific Islanders (18.3%), African Americans (21.4%), American 
Indians/Alaska Natives (33.9%), Hispanics/Latinos (16.6%), Caucasian (15.2%) (CDC, 2018). 
These estimates of smoking prevalence consider AAs in aggregate and often exclude some 
populations. Additionally, these studies fail to consider education, language, immigration status, 
age, socioeconomic status, and ethnic ancestry. For example, non-English-speaking populations 
may not be represented due to the use of English only language surveys, which is an important 
consideration since two-thirds of AAs are immigrants to the United States and 35% have low 
English proficiency (Chae et al., 2006; Davis et al., 2017). Sources of disparity, such as 
language, education, and immigration status, are important to examine as they may play a role in 
AAs’ smoking (Zhang & Wang, 2008). A Chinese and Korean tobacco use survey reported 
Cantonese-speaking Chinese men had higher current smoking rates than Chinese men in general 
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(Carr et al., 2005). Additionally, the California Health Interview Survey found that 23.4% of 
Asian males who do not speak English well or at all were current smokers, compared to 4% of 
Asian males who do speak English well (UCLA Center for Health Policy Research, 2018). 
Analysis of 2000 Census data by the Asian American Federation of New York Census 
Information Center indicates that a large subset of New York Chinese smokers are foreign born 
(75%), have limited English proficiency (63%), and do not have a high school diploma (42%) 
(Asian American Federation of New York Census Information, 2004). These factors serve as 
additional barriers to smoking cessation (Ja & Aoki, 1993).  
Tobacco Interventions  
Many effective tobacco interventions exist with aims to reduce smoking and smoking-
related health harms (Fiore, 2009). Tobacco interventions can be offered at the individual, 
family, and community level. Existing tobacco interventions include pharmacological products, 
behavioral counseling, self-help materials, and multicomponent interventions.  
Pharmacological Interventions  
Pharmacological cessation products include Nicotine Replacement Therapy (NRT) and 
oral medications such as bupropion and varenicline. NRT include nicotine patches, nicotine gum, 
nicotine nasal spray, nicotine inhaler, and nicotine lozenges. NRT works by delivering small 
doses of nicotine to the body via skin absorption or membranes of the mouth (Stead et al., 2012). 
NRT reduces withdrawal symptoms and cravings, increasing the likelihood of quitting (Stead et 
al., 2012). Bupropion is a smoking cessation aid that acts as an antagonist at nicotinic receptors 
to reduce cravings and withdrawal symptoms, while varenicline acts as an agonist to decrease 
cravings and pleasurable effects of tobacco. Both medications are taken orally. Three meta-
analyses reported NRT as an effective smoking cessation intervention (Etter & Stapleton, 2006; 
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Hughes et al., 2003; Wu et al., 2006). Research has shown that bupropion and varenicline are 
also effective smoking cessation interventions (Eisenberg et al., 2008; Wu et al., 2006). These 
pharmacological interventions can reduce smoking substantially for AAs. The nicotine patch (Fu 
et al., 2008: Ma et al., 2005; Wu et al., 2009) and varenicline (Nakamura et al., 2007; Tsai et al., 
2007) have preliminary evidence of short-term effectiveness among AAs. Ma et al. (2005) and 
Wu et al. (2009) supplemented nicotine patches with brief behavioral counseling.  
Health Education and Cognitive-Behavioral Counseling  
Health education and cognitive-behavioral counseling have also been found to be 
effective for smoking cessation. Health education and counseling consists of educating smokers 
about health harms, ways to quit, and how to change smoking behaviors and cognition (Fang et 
al., 2006). Counseling can be provided in an individual or group format. Meta-analyses 
examining randomized control trials show counseling as an effective form of treatment for 
smoking, with an odds ratio (OR) ranging from 1.20 to 1.64, which are modest effect sizes 
(Lichtenstein et al., 1996; Mojica et al., 2004). Similar results were apparent for AA smokers. A 
phone-counseling smoking cessation intervention showed effectiveness in a Chinese male 
smoker population, with 53.3% of men abstaining from smoking at the time they completed the 
program (Burton et al., 2010). Fang and colleagues (2006) found quit rates were higher for AA 
smokers in the health counseling intervention than the control group (56.3% vs 31.8%).  
Other forms of counseling include physician advice and utilization of quitlines. 
Physicians often advise patients to quit smoking in order to improve their overall health. 
Physician advice can be brief or part of a more intensive intervention. Stead et al. (2008) 
conducted a meta-analysis examining physician advice and found a small effect size. Those 
receiving physician advice had a higher rate of quitting than those not receiving physician advice 
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(OR = 1.74). A national network of quitlines exist in which smokers can call a toll-free number 
to receive telephone counseling (Fiore, 2009; North American Quitline Consortium (NAQC), 
2009). Tobacco cessation quitlines can be offered in multiple languages and have been found to 
be effective (Fiore, 2009; Lichtenstein et al., 2010; Zhu et al., 2002). Zhu et al. (2010) conclude 
that AAs are utilizing the quitline, with similar rates of successful smoking cessation (Zhu et al., 
2012).  
Self-Help Interventions  
Self-help interventions are usually comprised of educational materials, and cessation and 
maintenance manuals (e.g., books, videos). Self-help materials can reach a large number of 
smokers, are cost effective and do not require attendance (Davis et al., 1984; Prochaska et al., 
1993). Although cost effective, self-help interventions are less effective compared to other 
interventions (Davis et al., 1984). At this time, no published studies have examined the use of 
self-help materials in AAs.   
Multicomponent Interventions 
 Multicomponent interventions consist of two or more different types of interventions. 
Quitlines offer over the phone counseling in addition to other services such as providing 
educational material and NRT material (Fiore, 2009). Often, NRT is paired with behavioral 
counseling, which has shown to be effective by increasing quit rates by two-fold (Mojica et al., 
2004). However, most multicomponent interventions have a primary treatment, with 
supplemental treatments. If a primary treatment is apparent, it will be treated as a single 
component treatment.  
Other Intervention Methods 
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 Other smoking cessation interventions include media campaigns, community outreach, 
hypnosis, and acupuncture (Fiore et al., 2009). Currently there is insufficient evidence to support 
hypnosis and acupuncture as effective smoking cessation interventions (Fiore et al., 2009). 
Community outreach involves effort from the community to provide services to populations who 
have barriers to services or limited resources.  
Rationale for Systematic Review and Meta-Analysis 
Overall Effectiveness of Smoking Cessation Interventions Among AAs Across Studies is 
Unknown.  
Although there is much evidence supporting the effectiveness of the aforementioned 
smoking cessation interventions in the general population, there is less work that has been done 
within the AA population specifically. There are few studies that tested various interventions for 
smoking cessation within AAs specifically, but, to our knowledge, there have been no systematic 
reviews to determine the overall effectiveness of these interventions for AAs. Although these 
interventions differ from each other in many ways, these interventions also share similarities that 
warrant the use of meta-analytic methods (Webb, 2008). First, the research goals are similar, 
aiming for smoking cessation in each study. Second, many of the studies are multicomponent 
(Ma et al., 2005; Prochaska et al., 1993; Wu et al., 2009). Third, these studies include 
participants who share similar cultural worldviews. Fourth, there is overlap in the designs of the 
studies. Many studies are longitudinal, include follow up, and have similar statistical design. 
Lastly, other scholars have conducted meta-analyses to determine the effectiveness of smoking 
cessation interventions in the general population (Baillie et al., 1994) as well as ethnic 
populations (e.g., African Americans, Latinos) (Webb, 2008; Webb et al., 2010). AAs are often 
excluded from recent studies and trials due to language barriers and many studies do not report 
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on the breakdown of ethnicity; therefore, it is important to review smoking cessation among 
them (Chae et al., 2006). Although there is great diversity among AAs, they also share numerous 
similarities. According to Kim et al. (2001), AAs have been found to share similar cultural 
values of collectivism, conformity to norms, emotional self-control, family recognition through 
achievement, filial piety, and humility. These shared cultural values may be due to these cultures 
being heavily rooted in the Buddhist and Confucian philosophies (Kim et al., 2001). In most AA 
cultures, men are reported to smoke more than women, and demonstrate the largest gap in 
smoking rates between genders, with 17.5% males and only 6.5% females smoking (CDC, 
2005).  
Differences in Effectiveness Across Tailored vs Non-tailored Interventions is Unknown.  
Cultural responsiveness advocates argue that interventions are more effective when 
consistent with a population’s cultural norms, beliefs, and other characteristics unique to the 
group (e.g., American Psychological Association, 2003; Baldwin, et al., 1996; Barrera Jr. et al., 
2013; Bernal et al., 2009; Resnicow et al., 2000; Sue et al., 1991; Vega, 1992). Smoking 
cessation interventions can be and have been culturally tailored for AA populations. A meta-
analysis conducted by Huey and Tilley (2018) found that mental health treatments adapted for 
Asian American subgroups showed the largest effects when compared to non-culturally tailored 
treatments. Cultural tailoring can include surface structure, which involves matching intervention 
materials to characteristics of a population, such as changing the language or translation of 
materials, ensuring race matched interventionists, using race relevant epidemiological data and 
testimonials, and editing material to match AA history or images (Bernal et al., 1995; Bernal et 
al., 2009; Resnicow et al., 2000; Webb, 2008). Cultural tailoring can also include deep structure, 
which involves incorporating cultural, social, historical, environmental, and psychological forces 
SMOKING CESSATION INTERVENTIONS FOR AAs 14 
that influence the health behavior in the population, such as considering peer or family influence, 
migration, and acculturational stress (Resnicow et al., 2000). It is important to note how 
interventions take into account smokers’ cultural backgrounds and whether culturally tailored 
smoking cessation interventions are more effective for the AA population.  
Rationale for Exploring Moderators 
Smoking cessation interventions often differ in many ways, so it is important to examine 
different factors that may be associated with smoking cessation outcomes. Treatment intensity is 
the “dose” of intervention and varies across interventions. Low intensity treatments, such as self-
help materials, are often more cost effective and easily disseminated, but tend to be less 
effective. Low intensity treatments are useful for reaching a greater population, especially 
underserved smokers who have less resources or would not seek assistance otherwise (Webb, 
2008). High intensity treatments require more effort and engagement, such as visiting a clinic 
multiple times and frequent contact with health providers. High intensity treatments tend to yield 
better outcomes regarding smoking cessation, although they are often costly and difficult (Fiore 
et al., 2000). Treatment duration also varies from study to study and can play a role in the 
intensity of the treatment. However, longer treatment duration does not always equate to greater 
intensity. Overall, intense interventions tend to yield larger effects due to the robust dose-
response relationship between treatment intensity and outcome (Fiore et al., 2000), therefore, 
treatment intensity should be considered a moderator.  
Interventions for specific racial and ethnic groups often have some cultural adaptations. 
Culturally specific interventions consider culture throughout the development, implementation, 
and evaluation process. Researchers consider cultural values, beliefs, traditions, and 
characteristics that are specific to the racial/ethnic group. Cultural tailoring can include using 
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pictures and testimonials from other AAs, translating material into the group’s primary language, 
and providing race matched interventionists (Harris et al., 2001; Kreuter et al., 2003). Clinical 
practice guidelines state support for cultural tailoring remains inconclusive (Fiore et al., 2008). 
However, research suggests that culturally tailored interventions yield greater effects (Fiore et 
al., 2000), therefore, cultural tailoring should be considered a potential moderator.  
The term “smoking cessation” is operationalized differently in many studies. Research in 
this area has operationalized smoking cessation as no smoking at the time of assessment, point 
prevalence, prolonged abstinence, and continuous abstinence (Velicer et al., 1992). These 
measurements can also differ in time points (e.g., seven days, six months, etc). Additionally, 
smoking status can be self-reported or biologically validated via expired breath carbon 
monoxide, saliva/urine cotinine, or both. Biochemical verification is often preferred to reduce 
social desirability bias, response bias, and recall bias. Biochemical verification can increase 
smoking cessation as it holds smokers accountable compared to self-report; therefore, it could be 
a potential moderator.  
Flay and Petraitis’ (1994) Theory of Triadic Influence (TTI) is useful to better understand 
tobacco use (Flay & Petraitis, 1993). The TTI proposes that tobacco use can be influenced by 
three streams of influences: cultural environmental, intrapersonal, and social (Flay et al., 2009). 
Cultural environmental influences refer to “multiple sociocultural macro- environmental factors 
that contribute to attitudes toward specific behaviors” (Flay et al., 2009, p. 453). These macro-
environmental factors include immediate surroundings such as local crime and employment 
rates, poor career and academic options, media depictions of cigarette smoking, and culture. 
Other factors include knowledge, expectancies, and attitudes toward cigarette smoking. Social 
influences refer to “the social situation/context or microenvironment that contribute to social 
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normative beliefs about specific behaviors” (Flay et al., 2009, p. 453). Social influences include 
relationships with peers, parents, and immediate and extended family members. Therefore, it is 
important to consider how culture and acculturation may affect smoking cessation outcomes.    
The Theory of Planned Behavior can be used to understand health behavior; more 
specifically, it suggests that the likelihood of an individual engaging in a health behavior is 
correlated with his or her intention to engage in the behavior (Ajzen, 1991). Therefore, there is 
reason to believe that those who have intent to quit are more likely to successfully quit smoking.  
Breslau and Johnson (2000) found that the Fagerstrom Test for Nicotine Dependence 
(FTND)-defined nicotine dependence predicted smoking cessation, with nondependent smokers 
four times more likely to quit smoking than dependent smokers. Not only that, the Diagnostic 
and Statistical Manual Third Edition - Revised (DSM-III-R) defined nicotine dependence also 
predicted cessation, with similar results (Breslau & Johnson, 2000). This indicates that nicotine 
dependency could have an effect on smoking cessation outcomes.  
Current Study 
Despite high smoking rates, the majority of AA smokers want to quit (Babb et al., 2017). 
Therefore, it is important to examine smoking cessation interventions to assist AAs with 
successful quitting, as smokers who use assistance have higher quit rates than those who do not 
(Zhu et al., 2000). To our knowledge, the current review is the first meta-analytic examination of 
smoking cessation interventions among AA adults. Meta-analyses typically examine a 
combination of studies that are diverse in approach and methodology, therefore heterogeneity in 
effect sizes is possible (Higgins et al., 2002). Using meta-analytic technique allows a cohesive 
picture of the phenomenon to be captured (Cooper, 2009). Meta-analytic procedures are useful 
for comparing study findings by study characteristics, such that sources of systematic differences 
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across studies can be identified. Because meta-analyses include multiple samples, analyses are 
more reliable and generalizable (Cohn & Becker, 2003; Cooper, 2009). The main objectives of 
this review were to: (1) evaluate the effectiveness of smoking cessation interventions compared 
with control groups; (2) evaluate the effectiveness of culturally tailored smoking cessation 
interventions compared with non-culturally tailored smoking cessation interventions; and (3) 
investigate moderator variables (e.g., acculturation, intentions to quit, cultural tailoring, nicotine 
dependence, treatment intensity and duration, component type) that may play a role in the 
relationship between treatment groups and smoking cessation. Results from this meta-analytic 
review will provide researchers, healthcare providers, and smokers with information on the most 
effective interventions to increase smoking abstinence among AAs. 
Hypotheses 
1. Smoking cessation interventions for AAs would be more effective relative to control 
conditions (Burton et al., 2010; Fang et al., 2006; Fiore et al., 2009; Fu et al., 2008: Ma et 
al., 2005; Wu et al., 2009).   
2. Multicomponent interventions would have larger treatment effects than single component 
interventions (Fiore, 2009).  
3. Culturally tailored interventions would have larger treatment effects than non-culturally 
tailored interventions (Bernal et al., 2009; Huey & Tilley, 2018; Sue et al., 1991; Vega, 
1992).   
4. Interventions culturally tailored for AA subgroups would have larger treatment effects 
than interventions culturally tailored for AA broadly (Huey & Tilley, 2018).   
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5. It was expected that certain participant and treatment variables would moderate the 
relationship between treatment and smoking cessation outcomes. It was hypothesized that 
treatment effects would be: 
a. Smaller for smokers with higher nicotine dependence (Fiore, 2009).  
b. Larger for treatments with greater treatment intensity (Fiore, 2009).  
c. Larger for treatments with longer treatment duration (Fiore, 2009).  
d. Larger for smokers with stronger intention to quit (Fiore, 2009).  
e. Larger for smokers with higher acculturation (Zhang & Wang, 2008). 
Method 
Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 
guidelines are used to guide the reporting systematic reviews and meta-analyses of health care 
interventions (Liberati et al., 2009). The current study followed PRISMA guidelines, which 
include a 27-item checklist (Appendix A) and a four-phase information flow diagram (Figure 1). 
The PRISMA statement was used to assist with the appraisal of the literature, report findings, 
and to decrease report bias of systematic reviews and meta-analyses (Moher et al., 2009). The 
current study is registered in the Open Science Framework.   
Literature Search 
All articles were identified using these seven major databases: PsycINFO, PubMed, 
Cumulative Index to Nursing and Allied Health Literature (CINAHL), ScienceDirect, Google 
Scholar, Health Source: Nursing/Academic Edition, and Cochrane Central Register of Controlled 
Trials (CENTRAL). Additionally, articles were found through the examination of reference lists 
in past research as well as the review of pertinent journals in the field (e.g., Health Psychology). 
Clinical trial databases (e.g., clinicaltrials.gov), dissertation and thesis databases (e.g., 
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Dissertation Direct), and unpublished manuscripts were also reviewed to minimize selection 
bias. Researchers were identified and emailed to ask for any unpublished research and 
manuscripts. The PICO (patient/problem, intervention, comparison, outcome) strategy was used 
to guide the development of search terms (Santos et al., 2007). The problem identified is 
smoking in the population of AAs. The interventions being evaluated are smoking cessation 
interventions. The treatment group is compared to a control group (no treatment, waitlist, 
standard treatment). The outcome of interest is success or failure to quit smoking at time one 
post intervention. Searches were conducted using Boolean operators (OR/AND) with a variation 
of these terms: “Asian,” “Asian American,” “smoking,” “tobacco,” “tobacco dependence,” 
“cigarettes,” “interventions,” “programs,” “cessation,” and other related search terms. 
Furthermore, these search terms were used in combination with specified ethnicities, such as 
“Chinese,” “Chinese American,” and “Vietnamese.” See Appendix B for more search terms.  
Inclusion Criteria 
Inclusion criteria included: (1) studies examining and/or evaluating interventions that aim 
to reduce smoking; (2) interventions targeting AA smokers or with an overrepresentation of AAs 
(i.e., about 50% of the sample); (3) adult participants (over age 17); (4) randomized controlled 
trials (RCTs) that provides quantitative outcomes; and (5) studies written in English. 
Exclusion criteria 
Exclusion criteria included: (1) interventions targeting nonsmokers; (2) interventions 
targeting non-AA smokers; (3) interventions including AA smokers younger than 18; (4) 
interventions targeting health behaviors other than smoking; (5) studies that are not written in 
English; (6) studies that are not RCTs and do not provide quantitative outcomes; and (7) meta-
analyses and literature reviews.   
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Article Selection and Coding Procedures 
Article screening and selection was conducted in March 2019. Article selection and data 
extraction started with the principal investigator screening articles based on titles, abstracts, and 
full text. Eligible articles were then screened by a team of researchers. Researchers 
independently screened articles based on the full text. A second researcher screened and verified 
20% of the eligible references to minimize bias (Soilemezi & Linceviciute, 2018). 
Disagreements on the eligibility of articles were discussed during consensus meetings until 
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Figure 1 
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 A coding manual and data extraction forms were created a priori and used to extract 
relevant information including: (1) the citation; (2) article characteristics (e.g., publication year); 
(3) study design; (4) sample; (5) predictor variables (e.g., treatment type, treatment intensity, 
treatment setting, treatment duration); (6) outcomes measured (e.g., smoking status, effect size); 
(7) unit of analysis; (8) cultural tailoring that were made primarily for AA smokers (e.g., 
language, translation of materials); (9) risk of bias (e.g., research design, how outcome is 
measured (self-report vs. biochemical verification)); and (10) coder characteristics (e.g., date 
coded) (Cooper, 2015; Higgins et al., 2011). Regarding cultural tailoring, we coded whether the 
intervention was tailored specifically for AA subgroups (e.g., inclusion of Chinese American-
specific norms and beliefs), tailored broadly for AA (e.g., use of AA cultural values such as the 
importance of familial support), tailored broadly for ethnic/cultural minorities (e.g., reframed 
Western concepts of smoking), or not culturally tailored at all (Huey & Tilley, 2018). When 
effect sizes could not be calculated due to missing information, attempts were made to contact 
the author(s) of the article to obtain the information needed to calculate the effect size. Only 
studies with calculable effect sizes for AAs were included in this meta-analysis. When more than 
one study implemented the same intervention, but with a different sample, both studies were 
included and examined. The data screening and extraction form is presented in Appendix C.  
Researchers used Microsoft Excel Online to code articles. Microsoft Excel Online allows 
coders to code simultaneously and be updated live online. A pilot test was conducted before 
initiating official coding by the team of trained researchers to ensure clarity of variables. Two 
studies were randomly selected and coded by researchers. Discrepancies were discussed and the 
coding manual was revised based on coders’ feedback in order to have a shared understanding of 
the items in the manual and consistency among coders in using the manual. Articles were evenly 
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and randomly distributed to coders. Coder reliability was established by having 20% of the 
identified articles double coded by a second coder (Wilson et al., 2003). These reliability checks 
occurred throughout the coding process to ensure major discrepancies were resolved. 
Statistical Analyses 
Twenty-eight studies representing a sample of 17,660 participants were included in the 
analysis. Main effect sizes for each study were calculated in terms of the odds ratio (ESOR). The 
ESOR compared treatment and control groups on the relative odds of smoking cessation using a 
random effects model, which assumes that effect sizes vary for each study used in the meta-
analysis, and allows for greater generalization of findings (Cooper, 2015). ESOR of 1.0 were 
interpreted as no relationship. ESOR less than 1.0 were interpreted as a negative relationship (the 
odds of cessation are greater in the control condition) and ESOR greater than 1.0 were interpreted 
as a positive relationship (the odds of cessation are greater in the intervention condition) 
(Cooper, 2015). ORs were calculated using the Comprehensive Meta-Analysis (CMA) (Version 
3.0) software. ORs are based on the non-normal chi-square distribution, therefore analyses were 
conducted on the logged-OR, which is an approximately normal distribution. All effect size 
estimates are reported with 95% confidence intervals (CIs). CIs that do not include 1.0 are 
considered statistically significant at the p < .05 level.   
First, ESOR were computed for each study. All studies reported proportions of smoking 
cessation, which were entered into a 2x2 table (Figure 2), with rows indicating the number of 
participants who successfully quit smoking and those who did not, and columns representing the 
number of participants who received the intervention and those who did not. Participants who 
dropped out of the intervention were assumed to have not quit smoking. Cell frequencies were 
then converted into ESOR using the following formula: ESOR = ad/bc, where a and b refer to the 
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number of participants with successful smoking cessation in the treatment and control groups, 
respectively; and c and d are the number of participants with unsuccessful cessation in the 
intervention and control groups, respectively (Cooper, 2015).  
Figure 2 
Proportions of Smoking Cessation 
 Intervention (n) Control (n) 
Quit (n) a b 
Not Quit (n) c d 
Odds ratio: ________ >1  (intervention)    0  (no relationship)    <1  (control) 
 
 Second, ESOR were transformed into logged odds ratios using CMA to correct for 
potential sample size bias. The logged odds-ratios were converted back into general odds ratios 
to compute descriptive statistics and CIs. Homogeneity tests were conducted based on 
the Q statistic developed by Hedges and Olkin (1985). The power to detect heterogeneity within 
a small number of studies can be low, therefore the I2 statistic, an alternative to Q, was used to 
estimate the degree of inconsistency in studies’ outcomes (Higgins & Thompson, 2002). 
Third, after effect sizes for each study were calculated, an average effect size, combining 
all studies, was calculated using CMA. The average effect size was weighted based on the 
number of participants in each sample. To calculate the average effect size, each effect size was 
multiplied by the sample size. Then the sum of these products was divided by the sum of the 
sample sizes (Cooper, 2015).  
Fourth, after analysis of overall effect size, moderator analyses were conducted to address 
sample and study characteristics that may alter the effect size. Moderators were analyzed if Q 
was significant, if moderators were characteristic of at least 10 studies (Borenstein et al., 2009), 
and if there was significant unexplained variability in effect sizes (Lipsey & Wilson, 2001). 
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Categorical variables were tested using meta-regression models in SPSS Statistics, Version 25, to 
test multiple moderators sequentially. Categorical moderator variables (such as “culturally 
tailored” vs. “not culturally tailored”) were given binary codes (0 or 1). Meta-regression is 
similar to multiple regression in which effect sizes are evaluated as criterion variables and study 
characteristics are the predictors (Cooper, 2015; Hartung et al., 2008; Shelby & Vaske, 2008).   
 Lastly, a forest plot was created to illustrate the distribution of ESOR and the CIs around 
the individual effect sizes. The forest plot also identifies any outliers that should be considered 
when interpreting the overall results.  
Results 
Sample Description 
 Characteristics of the individual studies included in the analysis and coding information 
are described in Table 1. All studies were RCTs. The sample size across studies ranged from 30 
to 1860 participants (M = 630.71, SD = 510.78), the mean ages ranged from 20.7 to 58.3 years 
old (M = 43.42, SD = 7.26), and male percentage ranged from 60% to 100% (M = 88.08, SD = 
10.18). Of the overall sample, 88% were males. Ethnicity breakdown is as follows: 72% 
Chinese, 17% Korean, 10% Japanese, 1% Thai. 
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Table 1 
 
Characteristics of Individual Studies included in Meta-Analysis 
 
Study ID N OR DOE TYPE COM CUL LOC INT DUR OUT BIO 
Abdullah et al. 
(2005) 
1 952 2.26 + 3 1 4 1 2 5 3 1 
Chan et al. (2008) 15 1483 1.60 + 6 1 4 1 2 2 3 1 
Chan et al. (2010) 12 719 4.83 + 3 1 4 1 3 3 3 0 
Chan et al. (2011) 13 1154 1.87 + 3 1 4 1 3 4 3 0 
Chan et al. (2012) 14 1860 1.06 + 3 0 4 1 2 3 3 1 
Fagerstrom et al. 
(2010) 
20 893 2.71 + 5 1 4 1 3 4 4 0 
Fang et al. (2006) 21 66 2.37 + 1 1 1 0 2 1 3 1 
Gu (2015) 23 900 25.63 + 3 1 4 1 3 3 –    –    
Ito et al. (2006) 27 697 0.82 - 7 1 4 1 1 6 –    1 
Kim et al. (2005) 32 401 2.13 + 3 0 4 1 2  –    2 0 
Kim et al. (2012) 33 30 4.00 + 3 1 2 0 3 4 3 0 
Kim et al. (2015) 36 109 4.94 + 3 1 2 0 3 4 6 0 
Lam et al. (2012) 40 1154 3.36 + 3 1 4 1 3 5 3 0 
Liao et al. (2018) 63 1369 3.43 + 7 0 4 1 3 5 5 0 
McDonnell et al. 
(2011) 
47 1409 0.85 - 7 0 2 0 2 –    4 1 
Moskowitz et al. 
(2016) 
49 403 1.11 + 7 0 2 0 2 5 4 1 
Nakamura et al. 
(2007) 
51 618 2.16 + 5 1 4 1 3 4 4 0 
Nakamura et al. 
(2017) 
50 210 2.19 + 5 0 4 1 2 5 –    0 
Paek et al. (2014) 54 332 1.63 + 7 0 4 1 2 5 4 0 
Sheng et al. (2012) 60 257 3.71 + 2 1 4 1 3 4 4 0 
Sun et al. (2009) 61 211 4.68 + 1 1 4 1 3 4 –    0 
Tong et al. (2018) 65 205 0.77 - 6 1 2 0 3 4 4 0 
Tsai et al. (2007) 67 250 3.09 + 5 1 4 1 3 4 4 0 
Wang et al. (2017) 53 1077 1.49 + 4 1 4 1 2 5 3 0 
White et al. (2013) 41 201 1.78 + 3 1 4 1 1 –    3 0 
Wu et al. (2005) 18 139 4.20 + 3 1 2 0 3 5 5 0 
Wu et al. (2017) 10 369 2.09 + 4 1 4 1 1 6 5 1 
Yang et al. (2018) 52 192 6.64 + 3 0 4 1 3 3 –    0 
Note. –  = missing data; N = number of participants in the analysis; OR = odds ratio; DOE = direction of effect (+ = treatment; - = control); TYPE 
= primary treatment type (1 = nicotine replacement; 2 = bupropion; 3 = individual counseling; 4 = physician advice; 5 = varenicline; 6 = health 
education; 7 = other); COM = component (0 = single; 1 = multiple); CUL = cultural tailoring (1 = AAs broadly; 2 = AA subgroups; 3 = 
ethnic/cultural minorities broadly; 4 = no cultural tailoring); LOC = location of intervention (0 = United States; 1 = Asian country); INT = 
treatment intensity (1 = low; 2 = moderate; 3 = high); DUR = treatment duration (1 = within a day; 2 = within a week; 3 = within a month; 4 = 
within 3 months; 5 = within 6 months; 6 = within 12 months); OUT = outcome measure (1 = no smoking at the time of the assessment/when 
interviewed; 2 = 24-hour point prevalence abstinence (no smoking for past 24 hours); 3 = 7-day point prevalence abstinence; 4 = 1 month (28-
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General Effects 
 The meta-analysis assessing smoking cessation effectiveness produced an average OR of 
2.33 (95% CI = 1.77 to 3.06, n = 28), which is a small to medium effect size. This statistic 
indicates greater odds of smoking cessation in the treatment conditions compared to the control 
conditions. Figure 3 is a forest plot representing the effect sizes of each individual study included 
in the analysis. The homogeneity tests were significant, indicating variability in effect sizes (p = 
.00, I2 = 86.48) due to factors other than sampling and treatment error. Overall, results suggest 
that smoking cessation interventions were more effective than control conditions for AAs.   
Figure 3 
Forest Plot of Effect Sizes of Studies 
 
Note. The squares represent the odd ratios value. CI = confidence interval.  
Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit Z-Value p-Value
Abdullah et al. (2005) 2.261 1.466 3.486 3.691 0.000
Chan et al. (2008) 1.600 1.035 2.472 2.117 0.034
Chan et al. (2010) 4.829 2.600 8.971 4.984 0.000
Chan et al. (2011) 1.872 0.951 3.683 1.815 0.070
Chan et al. (2012) 1.056 0.859 1.300 0.520 0.603
Fagerström et al. (2010) 2.712 2.068 3.558 7.206 0.000
Fang et al. (2006) 2.368 0.830 6.755 1.612 0.107
Gu (2015) 25.632 14.560 45.124 11.242 0.000
Ito et al. (2006) 0.823 0.507 1.336 -0.787 0.431
Kim et al. (2005) 2.126 1.258 3.591 2.818 0.005
Kim et al. (2012) 4.000 0.849 18.836 1.754 0.080
Kim et al. (2015) 4.941 1.803 13.540 3.106 0.002
Lam et al. (2012) 3.362 1.735 6.515 3.594 0.000
Liao et al. (2018) 3.426 1.624 7.226 3.234 0.001
McDonnell et al. (2011) 0.849 0.588 1.224 -0.877 0.381
Moskowitz et al. (2016) 1.107 0.548 2.237 0.283 0.777
Nakamura et al. (2007) 2.160 1.438 3.245 3.710 0.000
Nakamura et al. (2017) 2.185 1.078 4.427 2.168 0.030
Paek et al. (2014) 1.627 1.052 2.516 2.190 0.029
Sheng et al. (2012) 3.707 1.856 7.402 3.713 0.000
Sun et al. (2009) 4.680 2.529 8.658 4.916 0.000
Tong et al. (2018) 0.769 0.379 1.558 -0.730 0.465
Tsai et al. (2007) 3.088 1.840 5.184 4.267 0.000
Wang et al. (2017) 1.488 0.964 2.295 1.796 0.072
White et al. (2013) 1.776 0.944 3.341 1.780 0.075
Wu et al. (2005) 4.200 1.972 8.946 3.720 0.000
Wu et al. (2017) 2.088 0.943 4.622 1.815 0.069
Yang et al. (2018) 6.641 0.338 130.331 1.247 0.213
2.329 1.771 3.064 6.042 0.000
0.01 0.1 1 10 100
Favours A Favours B
Meta Analysis
Meta Analysis
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Demographics 
 Average age for each study was divided into four groups (21-30 years old, 31-40 years 
old, 41-50 years old, and 51-60 years old). A permutation test indicated there were no significant 
differences between age groups ( = 6.43, df = 3, p = 0.09). A Kruskal-Wallis rank sum test 
confirmed this conclusion,  = 6.01, df = 3, p = 0.11. The interaction between age and treatment 
effects was not statistically significant (Q(3) = 4.18, p = .24), therefore age did not moderate the 
odds of smoking cessation. Percentage of male participants in each study were also divided into 
four groups (50-70%, 71-80%, 81-90%, 91-100%). A permutation test indicated there were no 
significant differences between percentage of male participants per study,  = 1.41, df = 3, p = 
.70. A Kruskal-Wallis rank sum test confirmed this conclusion,  = 1.69, df = 3, p = 0.64; 
therefore percentage of males did not moderate the odds of smoking cessation (Q(3) = .9, p = 
.83). Ethnicity was divided into five groups (Chinese, Japanese, Korean, Thai, and mixed). A 
permutation test indicated there were no significant differences between ethnic groups,  = 2.05, 
df = 3, p = 0.56. A Kruskal-Wallis rank sum test confirmed this conclusion,  = 1.74, df = 3, p = 
0.63. See Table 2 for characteristics of individual types of treatment.  
Table 2 
 
Odds Ratios, Confidence Intervals, and Significance Values by Moderator Variable for Smoking 
Cessation Interventions with Asians and Asian Americans  
 
Variable N OR CI P 
Total sample 28 2.33 (1.77, 3.06) .00 
Demographic/Clinical moderators     
   Male percentage     
      50-70% 2 1.30 (.50, 3.36) .60 
      71-80 2 2.25 (1.52, 3.33) .00 
      81-90 10 2.15 (1.51, 3.06) .00 
      91-100% 12 2.70 (1.57, 4.65) .00 
   Age     
      21-30 1 2.37 (.83, 6.76) .12 
      31-40 9 2.30 (1.56, 3.40) .00 
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Variable N OR CI p 
      41-50 11 2.32 (1.61, 3.35) .00 
      51-60 4 1.32 (.87, 2.00) .20 
   Asian ethnicity     
      Chinese 15 2.81 (1.77, 4.49) .00 
      Korean 6 1.70 (1.04, .75) .03 
      Japanese 3 1.55 (.79, 3.03) .20 
      Thai 1 1.78 (.94, 3.34) .08 
      Mixed 3 2.77 (2.19, 3.50) .00 
Theory relevant moderators     
   Primary treatment type     
      NRT 2 3.82 (2.08, 7.03) .00 
      Bupropion 1 3.71 (1.86, 7.40) .00 
      Counseling 12 3.34 (1.85, 6.04) .00 
      Physician advice 2 1.61 (1.10, 2.35) .01 
      Varenicline 4 2.57 (2.11, 3.14) .00 
      Health education 2 1.17 (.58, 2.38) .66 
      Other 5 1.27 (.81, 1.10) .29 
   Treatment intensity     
      Low 3 1.37 (.75, 2.52) .31 
      Moderate 10 1.49 (1.17, 1.89) .00 
      High 15 3.57 (2.42, 5.28) .00 
   Treatment duration     
      Within a day 1 2.37 (.83, 6.76) .11 
      Within a week 1 1.6 (1.04, 2.47) .03 
      Within a month 4 5.25 (.84, 32.83) .08 
      Within 3 months 9 2.61 (1.91, 2.57) .00 
      Within 6 months 8 2.13 (1.60, 2.84) .00 
      Within 12 months 2 1.24 (.50, 3.07) .64 
   Cultural tailoring     
      Tailored specifically for AA subgroups 6 1.77 (.90, 3.48) .10 
      Tailored broadly for AA  1 2.37 (.83, 6.76) .11 
   Location     
      United States 7 1.83 (.99, 3.36) .05 
      Asia 21 2.50 (.84, 3.40) .00 
   Intervention components     
      Single 9 1.41 (1.03, 1.92) .03 
      Multiple 19 2.87 (2.07, 3.96) .00 
   Cessation verification     
      Biochemical 19 2.52 (2.05, 3.10) .00 
      Self-report 8 1.30 (.98, 1.72) .07 
   Smoking status outcome     
      24 Hour 1 2.13 (1.26, 3.59) .01 
      7 Day  10 2.03 (1.45, 2.85) .00 
      1 Month 8 1.75 (1.17, 2.60) .01 
      6 Month 3 3.15 (2.03, 4.90) .00 
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Variable N OR CI p 
      12 Month 1 4.94 (1.80, 13.54) .00 
 
Intervention Components 
 Multi-component interventions are defined as having more than one type of treatment 
(e.g., counseling and nicotine replacement therapy). The treatment effect for single component 
interventions was OR = 1.41 (95% CI 1.03 to 1.92, p = .03, n = 9). The effect for multi-
component interventions was OR = 2.87 (95% CI 2.07 to 3.96, p = .00, n = 19), indicating a 
small to medium effect size. A permutation independence test was conducted to compare 
treatment effect between single component and multi-component interventions and found no 
significant differences between the two types of treatment, Z = -1.58, p = 0.11. A Wilcox test 
also confirmed the result, W = 53, p = 0.12. These results suggest multi-component interventions 
are not significantly more effective in treating smoking than single component interventions. The 
number of intervention components does not impact odds of smoking cessation (Q(1) = .02, p = 
.88).  
Cultural Tailoring 
 Of the 28 studies included, seven studies were conducted in the United States and 21 
studies were conducted in Asia. Of the seven U.S. studies, 100% were coded as culturally 
tailored. Cultural tailoring is conceptualized as designing or adapting intervention components to 
fit a cultural minority population (Pasick et al., 1996). Of the 21 Asian studies, none described 
cultural tailoring; therefore, studies conducted in Asia are not assessed as part of the analyses. 
Since all U.S. studies were coded as culturally tailored, a comparison of culturally tailored verses 
non-culturally tailored studies was not possible; therefore, the hypothesis regarding culturally 
tailoring could not be tested. A permutation test comparing U.S. studies that were tailored for 
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AAs broadly verses AA subgroups was not significant,  = 0.46, df = 2, p = 0.80. A Kruskal-
Wallis rank sum test also supports the above result,  = 0.16, df = 2, p = 0.92. See Table 2 for 
ORs associated with each type of cultural tailoring. Furthermore, an independent permutation 
test revealed there were no differences between studies that were only linguistically tailored and 
studies that included cultural tailoring features in addition to being linguistic tailoring, Z = -0.64, 
p = 0.52. A Wilcoxon rank sum test confirms this finding, W = 68, p = 0.92.  
Nicotine Dependency 
 The Fagerstrom Test for Nicotine Dependence was used to assess baseline nicotine 
dependency in 15 studies. Scores were rated on a scale from 1 to 4 (1 = low, 2 = low to 
moderate, 3 = moderate, 4 = high). A Mann-Whitney U test was conducted to compare the effect 
of smoking cessation between low, low to moderate, moderate, and high nicotine dependence. A 
non-parametric test was used as there were not enough observations to conduct a one-way 
ANOVA. There was not a significant effect of baseline severity of nicotine dependence on 
smoking cessation,  = 3.38, df = 2, p = .18.  
Treatment Intensity  
 Treatment intensity was rated on a scale from 1 to 3, where 1 = low intensity (e.g., 
passive receipt of materials, brief phone call, no clinic visit), 2 = moderate intensity (e.g., one 
clinic visit, telephone counseling sessions), 3 = high intensity (e.g., multiple clinic visits, 
frequent contact with staff, adherence monitoring). A nonparametric one-way between-studies 
Kruskal-Wallis was conducted to compare the effect of smoking cessation between low, 
moderate, and high intensity interventions. There was a significant effect of treatment intensity 
on smoking cessation for the three levels of intensity,  = 9.77, df = 2, p = .01. Post hoc 
comparisons using the Tukey and Kramer test indicated that the ORs for the high intensity 
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treatment differed significantly from the moderate intensity group (p = .02). The low intensity 
treatment was not significantly different than the moderate (p = .95) or high intensity treatment 
(p = .09). See Table 2 for ORs associated with each type of intensity. Results suggest treatment 
intensity is a moderator, with higher intensity treatments predicting higher odds of smoking 
cessation (Q(2) = 10.07, p = .01).  
Treatment Duration 
 Treatment duration varied from each study, ranging from one day to 12 months with 68% 
being three to six months long. A permutation test revealed there were not significant differences 
between the different durations of treatment,  = 3.71, df = 5, p = 0.59. Results from a Kruskal-
Wallis test confirmed this result,  = 3.41, df = 5, p = 0.64. Moderation analyses revealed length 
of treatment does not impact the odds of smoking cessation (Q(5) = 4.52, p = .48). Table 2 
provides characteristics of the treatment durations.  
Other Factors 
 Hypotheses were made about intention to quit and acculturation predicting smoking 
cessation, however, there were not enough studies measuring these two variables to run 
moderation analyses. Average ESOR for studies measuring intention to quit was 1.56 (95% CI 
0.98 to 2.31, p = .06, n = 4), whereas average ESOR for studies measuring acculturation was 1.69 
(95% CI 0.74 to 4.30, p = .2, n = 4), with both indicating a small effect size.  
Treatment Type 
 Primary treatment types included: NRT, bupropion, individual counseling, physician 
advice, varenicline, health education, or other. As previously mentioned, for multicomponent 
treatments, whatever treatment was stated as primary was coded as such. Table 2 shows ORs 
associated with each type of treatment. A permutation test indicated there were no significant 
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differences between treatment type,  = 8.27, df = 6, p = .22. The type of treatment did not 
moderate the odds of smoking cessation (Q(6) = 8.3, p = .27).  
Location of Intervention 
 The treatment effect for interventions conducted in the United States was OR = 1.83 
(95% CI .99 to 3.36, p = .05, n = 7), indicating a small to medium effect size. The treatment 
effect for studies conducted in an Asian country (Japan, Thailand, Korea, China) was OR = 2.5 
(95% CI 1.84 to 3.4, p = .00, n = 21), indicating a small to medium effect size. An independent  
permutation test and Mann Whitney U were conducted to compare treatment  
effect between interventions located in the United States and Asian countries. Results revealed 
there was not a significant difference between interventions conducted in the United States and 
interventions conducted in Asia, Z = -0.63613, p = 0.52 (W = 71, p = 0.91). These results suggest 
interventions for AAs are not significantly more effective in Asian countries than the United 
States. Location of the treatment did not impact treatment effects (Q(1) = .61, p = .43).  
Cessation Verification 
 The effect size when smoking status was verified biochemically was 2.52 (95% CI 2.05 
to 3.10, p = .00, n = 20), indicating a small to medium effect size. When smoking status was not 
biochemically verified, the effect size was 1.30 (95% CI 0.98 to 1.72, p = .07, n = 8), indicating a 
small effect size. An independent permutation test revealed there was a significant difference 
between  studies with biochemical verification and studies with only self-report, Z = -2.40,  p = 
.02. Moderation analyses suggest studies that include a biochemical verification component 
predict higher odds of smoking cessation than studies that use self-report (Q(1) = .6.9, p = .01).  
Smoking Status Outcome Measure 
SMOKING CESSATION INTERVENTIONS FOR AAs 34 
 Studies differed on the primary outcome measure. The differences between primary 
outcome measures were not significant ( = 5.84, df = 4, p = .21.). Smoking status outcomes did 
not have an impact on odds of smoking cessation (Q(4) = 5.31, p = .26). See Table 2 for ORs. 
Risk Bias 
 One hundred percent of studies used true randomization for allocation of participants, 
therefore eliminating selection bias. Regarding performance bias, only two studies were double 
blind experiments, 12 studies were single blind experiments, and 14 studies did not include a 
blinding component.  
Discussion 
The current meta-analysis aimed to examine the effectiveness of smoking cessation 
interventions for AAs and different factors that may influence treatment effectiveness. Twenty-
eight trials of smoking cessation interventions were included, representing outcome data on 
17,660 smokers. Results revealed a small to medium effect size (OR = 2.33), indicating smoking 
cessation interventions are effective for AAs compared to control, placebo, and waitlist groups.  
USDHS’ clinical practice guidelines (Fiore et al., 2008) for treating tobacco dependence 
state that there is strong evidence for the effectiveness of cessation interventions for all smokers, 
including different racial and ethnic minorities (Baillie et al., 2004; Fiore et al., 2008). Results 
from this meta-analysis are consistent with previous research showing that smoking cessation 
interventions are effective for the general population. All interventions included in this meta-
analysis were found to be more effective than control conditions, except for health education (p = 
.66) and “other” types of interventions (p = .29), which included providing health risk appraisals 
and genetic feedback on cancer risk. This meta-analysis found a medium to large effect size (OR 
= 3.82) for NRT, which is higher than the what previous meta-analyses have found for the 
SMOKING CESSATION INTERVENTIONS FOR AAs 35 
general population (Etter & Stapleton, 2006; Wu et al., 2006). Regarding bupropion and 
varenicline, this study generated a large effect size (OR = 3.71) and a medium effect size (OR = 
2.57) respectively, which is also higher than previously found (Wu et al., 2006). This study 
generated a medium to large effect size (OR = 3.34) for counseling while other meta-analyses 
found small effect sizes, with ORs ranging from 1.20 to 1.64 (Lichtenstein et al., 1996; Mojica et 
al., 2004). Overall, these results are consistent with previous research.  
The current meta-analysis demonstrates that smoking cessation interventions are effective 
for AAs. This is particularly important given that AAs along with Native Americans have the 
least representation in clinical trials of smoking cessation interventions (Cox et al., 2011). 
Results from this meta-analysis (OR = 2.33, 95% CI = 1.77 to 3.06, n = 28) are comparable to 
other meta-analyses evaluating smoking cessation in ethnic/racial minority groups in the U.S. 
Webb (2008) conducted a meta-analysis with African Americans which yielded a small effect 
size, with an average OR of 1.41 (95% CI 1.16 to 1.73, n = 19). When evaluating smoking 
cessation for Hispanics, Webb et al. (2010) found an overall OR of 1.54 (95% CI 1.09 to 2.16, n 
= 5), which is a small effect size. This meta-analysis generated a higher OR and wider CIs than 
Webb (2008) and Webb et al. (2010). It could be related to all seven U.S. studies being culturally 
tailored, compared to just the majority studies of Webb (2008) and Webb et al. (2010) being 
culturally tailored, as researchers argue that interventions are more effective when consistent 
with a population’s culture (e.g., American Psychological Association, 2003; Baldwin, et al., 
1996; Barrera Jr. et al., 2013; Bernal et al., 2009; Resnicow et al., 2000; Sue et al., 1991; Vega, 
1992).  
Clinical practice guidelines (Fiore et al., 2008) graded research supporting cultural 
tailoring as “C,” indicating “no recommendation for or against” the service (U.S. Preventative 
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Services Task Force, 2018). Because all studies conducted in the U.S. were culturally tailored, it 
was not possible to the test whether culturally tailored interventions were more effective than 
non-culturally tailored interventions. Moreover, the concept of cultural tailoring is researched 
within contexts where non-White individuals are minorities (Pasick et al., 1996), thus, the studies 
based in Asia did not describe tailoring elements. At the same time, it is reasonable to assume 
that intervention elements were specific to that cultural context. Contrary to our hypothesis, we 
did not find a significant difference between studies culturally tailored for AA subgroups (n = 6) 
and studies culturally tailored for AA broadly (n = 1). A small sample size (n = 7) could explain 
the non-significance. Also, cultural tailoring can be widespread, ranging from using culturally 
syntonic language, to using correct content like cultural values, knowledge, and traditions, to 
considering context, such as acculturative stress (Bernal et al., 1995). Hall et al. (2016) suggest 
that some cultural modifications, such as cultural content and values, will more strongly impact 
outcomes compared to more minor modifications, such as language translation, as it 
encompasses more of the specific cultural characteristics. The majority of studies (n = 4) that 
were coded as culturally tailored only had a tailored language component, which is needed for 
non-English speaking populations. There were three studies that included more cultural 
components, such as using race related statistics and addressing cultural beliefs. Future studies 
should compare interventions using surface structure and deep structure cultural tailoring 
(Resnicow et al., 2000).  
In the current meta-analysis, the majority of interventions were of high treatment 
intensity, and treatment intensity moderated treatment effectiveness. These findings support 
previous research (Raw et al., 1998). High intensity treatments require more patient engagement, 
as it often involves patients visiting the clinic, contacting providers, and actively participating 
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(e.g., group therapy, using NRT every day). Patient engagement, defined as patients and 
healthcare providers working in active partnerships at various levels across the healthcare 
system, has been shown to improve health outcomes and health care (Carman et al., 2013; 
Epstein & Street, 2008). A study conducted by Cunningham (2014) found that patients who were 
highly engaged were more likely to try to stop smoking than patients who were less engaged. 
Patient engagement allows smokers to track their progress, ask questions, and receive extra 
support (Carman et al., 2013). Patient engagement can also affect how providers interact with 
smokers. If smokers seem engaged and interested, physicians may be more likely to offer 
assistance and resources (Carman et al., 2013). In the current meta-analysis, treatment duration 
did not have a significant effect on smoking cessation outcomes. It is important to clarify that 
longer duration interventions do not equate greater intensity treatments or greater patient 
engagement; in fact, two interventions had a duration of 12 months but were coded as low 
intensity.  
The Society for Research on Nicotine and Tobacco developed recommendations for 
outcome assessment, including outcome measures and outcome verification (Benowitz et al., 
2002; Hughes et al., 2003). The recommended primary outcome is prolonged abstinence, defined 
as continuous abstinence following a 2-week grace period (Hughes et al., 2003). Secondary 
outcomes should be seven- and 30- day point prevalence; six and/or 12 month follow up should 
be used to examine long term treatment effects (Hughes et al., 2003). The majority of studies in 
this meta-analysis used seven-day point prevalence as the primary outcome whereas one month 
(28 days) continuous abstinence was the second most used outcome measure. The measure of 
smoking status was not shown to moderate the overall effectiveness of treatment. The odds of 
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smoking cessation were higher when 12 month sustained abstinence was the definition of 
quitting, however, only one study used this outcome measure.   
Biochemical verification, such as expired breath carbon monoxide or cotinine in urine, 
plasma, or saliva, is recommended compared to only self-report (Benowitz et al., 2002) due to 
possible underreporting (Patrick et al., 1994; Velicer et al., 1992) and bias (Dolcini et al., 1996). 
Over half of the studies in this meta-analysis used biochemical verification, specifically expired 
breath carbon monoxide. The use of biochemical verification moderated the overall effect of 
smoking cessation treatment. Studies that verified smoking status via biochemical verification 
had larger effect sizes. Knowledge that smoking cessation would be biologically validated may 
serve as an incentive to quit, as there is more accountability than self-report. Participant feedback 
on an intervention using biochemical feedback as an intervention component found that 
receiving information on smoker and nonsmoker smoke exposure motivated cessation in the 
short term (Saw et al., 2018; Tong et al., 2018).   
In this study, approximately 88% of participants were male, with five studies including 
only males. The overall sample was majority Chinese, older adult, and male, which is 
representative of the AA smoking population. Therefore, results implicate that smoking cessation 
interventions can improve the odds of cessation for majority AA smokers. Results revealed age 
and gender did not have a significant effect on smoking cessation. These results align with 
previous literature (Abdullah et al., 2006; Jarvis et al., 2013; Wetter et al., 1995). Although there 
were not significant differences, previous research has found that females are less likely to 
successfully quit smoking, more likely to relapse after quitting, and more likely to experience 
withdrawal symptoms compared to males (Abdullah, et al., 2006; Wetter et al., 1995).   
Limitations 
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There were several limitations to this meta-analysis that should be noted. First, there was 
a limited number of treatment studies (n = 28), therefore the results of this meta-analysis will 
need to be updated as more research is conducted. This also affected the moderator analyses, as 
there were insufficient observations of each moderator across studies to conduct a 
metaregression. Bornstein et al. (2009) recommends moderators being characterized in at least 
10 studies, whereas Fu et al. (2010) suggests four observations are needed in each group to run a 
moderator analysis. These moderator analyses should be considered preliminary due to the 
limited number of studies. Second, although these results are geared towards AAs, these results 
are not generalizable to all AAs. AAs are divided into subgroups, each with their own ethnic 
ancestry and cultural values. Specifically, this meta-analysis only included Chinese, Japanese, 
Korean, and Thai smokers. However, majority of the sample was Chinese, male, and older. 
Therefore, these findings may not generalize broadly to the AA population. Additionally, these 
findings may not generalize to populations with specific characteristics, such as pregnant 
women, adolescents/young adults, or individuals with medical or psychiatric problems. Third, 
cultural tailoring was difficult to assess as all studies targeted AA populations and many 
interventions were conducted in an Asian country. Additionally, researchers do not always 
provide information on cultural responsiveness, making it difficult to detect an effect of cultural 
tailoring (Huey & Polo, 2008). It is important for studies to highlight how interventions were 
culturally tailored to prevent mis- or underreporting of cultural tailoring. The studies included in 
this meta-analysis were all published in English, therefore studies published in another language 
with possible meaningful data were not able to be analyzed. Next, the methodological reporting 
of some studies made it difficult to extract demographic information. For example, some studies 
did not report the gender ratio or length of treatment. Some demographic information was 
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reported in different units across studies. For example, FTND scores were reported as 
frequencies, percentages, and average scores. Another limitation is that intention to quit was not 
assessed as a moderator. Research shows that intention to quit smoking predicts smoking 
cessation in the general population (Godin et al., 1992) as well as in subpopulations (Armitage, 
2007; Johnston et al., 2004; Norman et al., 1999). The Theory of Planned Behavior also indicates 
that intention to perform a behavior, predicts that behavior (Ajzen, 1991). Along with intention 
to quit, there are many other factors that are associated with intention to quit and smoking 
cessation that were not assessed, such as positive attitudes and perceived behavioral control 
(Bennet & Clatworthy,1999; Borland et al., 1991; Hu & Lanese, 1998; Maher & Rickwood, 
1997). Use of emerging tobacco products, such as electronic cigarettes, is increasing among 
young adults (Dai & Leventhal, 2019), yet, no intervention studies involving these products were 
available at the time of review. Lastly, to determine effectiveness, smoking cessation 
interventions often compare the intervention group to an active control group (Johnston et al., 
2020). It is possible that the variability of the comparator group impacted findings, as comparator 
groups could receive no behavioral support, usual care, or self-help materials. A study conducted 
by Johnston et al. (2020) gives support to the idea that researchers need to consider variability in 
comparator interventions when interpreting, comparing, and generalizing trial effect sizes.  
Implications 
These findings have clinical, research, and theoretical implications regarding smoking 
cessation in AAs. Clinically, healthcare providers should continue to encourage AAs to use 
smoking cessation interventions. Information from this meta-analysis should be incorporated into 
existing interventions, as well as considered when developing new interventions to increase the 
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odds of smoking cessation among AAs. Theoretically, this information can inform researchers on 
treatment methods among AAs.   
This meta-analysis paves way for more research in this area. First, more research 
comparing culturally tailored and non-culturally tailored interventions is needed to understand 
the role of culture with regards to smoking cessation in AAs. More specifically, research should 
investigate surface structure (e.g., language, relevant statistics) and deep structure (e.g., 
acculturative stress) components. Additionally, although cultural tailoring is conceptualized as 
modifications or adaptations for minority groups, future intervention studies—irrespective of 
implementation in a majority or minority culture—should describe key intervention components 
that are tailored for their target population. By doing so, others may more readily discern 
whether the intervention may be useful for a culturally similar population. Researchers should 
also consider using the same units or operational definitions to increase ability to identify and 
compare possible moderators. Researchers should also aim to examine cessation interventions 
for emerging tobacco products as well as nontraditional intervention methods, such as those with 
a technological component (e.g. online interventions, texting interventions, smartphone 
applications, etc). As more studies in this area are conducted, this meta-analysis should be 
updated with the new information.   
Conclusion 
 To summarize, findings show that overall, smoking cessation interventions are effective 
for AAs; therefore, AAs should be encouraged to engage in cessation interventions. However, it 
is imperative that more intervention research is conducted with this diverse population. In 
particular, increased research attention is needed for currently underresearched high disparity 
subpopulations, such as Vietnamese, Filipino, and Indian male smokers. Finally, more research 
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examining cultural factors that contribute to use and cessation and testing effectiveness of 
culturally tailored interventions would help reduce disparities, and potentially increase smoking 
cessation and improve health outcomes both in the short and long term.   
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Appendix A  
PRISMA Statement 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or 
both.  
 
ABSTRACT   
Structured 
summary  
2 Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and implications of 
key findings; systematic review registration number.  
 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is 
already known.  
 
Objectives  4 Provide an explicit statement of questions being addressed 
with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
 
METHODS   
Protocol and 
registration  
5 Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-
up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, 




7 Describe all information sources (e.g., databases with dates 
of coverage, contact with study authors to identify additional 
studies) in the search and date last searched.  
 
Search  8 Present full electronic search strategy for at least one 
database, including any limits used, such that it could be 
repeated.  
 
Study selection  9 State the process for selecting studies (i.e., screening, 
eligibility, included in systematic review, and, if applicable, 




10 Describe method of data extraction from reports (e.g., piloted 
forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators.  
 
Data items  11 List and define all variables for which data were sought (e.g., 
PICOS, funding sources) and any assumptions and 
simplifications made.  
 
Risk of bias in 
individual studies  
12 Describe methods used for assessing risk of bias of individual 
studies (including specification of whether this was done at 
the study or outcome level), and how this information is to be 
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used in any data synthesis.  
Summary 
measures  
13 State the principal summary measures (e.g., risk ratio, 




14 Describe the methods of handling data and combining results 
of studies, if done, including measures of consistency (e.g., I2) 
for each meta-analysis.  
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Appendix B  
Search Terms 










































1. Asian 2. Native Hawaiian 
3. Asian American 4. Hawaiian 
5. Pacific Islander 6. Tongan 
7. Vietnamese 8. Chamorran 
9. Vietnamese American 10. Samoan 
11. Chinese 12. Polynesian 
13. Chinese American 14. Micronesian 
15. Korean 16. Melanesian 
17. Korean American 18. South Asian 
19. Japanese  20. Southeast Asian 
21. Japanese American 22. East Asian 
23. Filipino 24. Asian immigrants 
25. Filipino American 26. Smoking 
27. Indian 28. Tobacco 
29. Indian American 30. Tobacco dependence 
31. Cambodian 32. Cigarettes 
33. Cambodian American 34. Tobacco intervention 
35. Thai 36. Tobacco cessation 
37. Thai American 38. Smoking cessation 
39. Laotian 40. Smoking intervention 
41. Laotian American 42. Tobacco programs 
43. Tahitians 44. Smoking dependence 
45. Maori 46. Smoking programs 
47. Fijians 48. Nicotine dependence  
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Appendix C 
 Data Screening and Extraction Form 
Study ID: Study Title: 
Year of study: Date of screening: Date of data extraction: 




1. General Information  
Publication type:  Journal Article   Book chapter     Other (specify e.g., manual) ____________________ 
Country of study: Language of the article:  
 
2. Study Eligibility 
Study Characteristics (Even if a study does not meet the inclusion criteria, all study characteristics 





Aim of study To examine or evaluate an intervention that aims to reduce 
smoking  
 Yes  
 No →Exclude   
 Unclear 
 
Participants Does the study primarily target Asian and/or Asian American 
smokers?  
 Yes  
 No →Exclude   
 Unclear 
 
Does the study include a sample of adult (18+) Asian and/or 
Asian American smokers? 
 Yes 
 No →Exclude   
 Unclear 
 
 Does the study include a specific sample (e.g., medical issues, 
pregnancies)? 
 Yes  
 No →Exclude   
 Unclear 
 
Sample size  If the study targets Asian and/or Asian American smokers, 




Does the study include non-Asian sample? If yes, what is the 




 What is the total (both Asian and non-Asian) sample size of 
the study? 
Total Sample:  
_____________ 
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Type of study 
 
 Original, peer reviewed and empirical articles 
 Dissertation/Thesis 
 Intervention protocols 
 Intervention pilot/feasibility studies  
 Intervention evaluation studies  
-  Randomized Controlled Trial (RCT) 
-  Cluster Randomized Controlled Trial (cluster RCT) 
-  Pre-post single group comparison  
-  Others: ___________________________________ 
 Yes  




 Systematic review/meta-analyses 
 Non-peer reviewed articles  
 Others: _________________________________________ 
No →Exclude    
Methodology  Does the study provide quantitative outcomes? 
 
 Yes  
 No →Exclude   
 Unclear 
 
 Does the study compare against a control group?  Yes  
 No →Exclude   
 Unclear 
 
Language Is the article written in English?  Yes  




Does the study include a description of the intervention 
studied or tested?  
 Yes  
 No →Email 




Summary of Assessment for Inclusion 
Include in review  Exclude from review  
Independently assessed, and then compared? Yes    No  Differences resolved  Yes    No  
Request further details?  Yes    No  Contact details of authors: (if further details 
needed) 
Notes: (i.e. What details are missing?) 
 
DO NOT PROCEED IF PAPER EXCLUDED FROM REVIEW 
 
3. Intervention details (*If the article mentions more than 1 intervention, for example an RCT, 
then we will code each of the intervention, including the treatment-as usual group) 
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What was the problem that this intervention was designed to address? 
 
 
Aim of study 
 
What was the study designed to assess? Are these clearly stated?  




Setting  Where did the intervention take place? (e.g., academic medical center, 
university teaching hospitals, rural, metropolitan, school, workplace, 
community, GP clinic) 
 
 




Participants  Where were participants recruited from? 
 
 
Mean/range of participants’ age: ______________________________ 
 
 
Gender composition of participants sample:  
Males (n):_______ Females (n):________ 
Males (%):_______ Females (%):________ 
 
 
Number of participants sample: 
Asian/Asian American: (n):_________ (%):__________ 
Non-Asian (if any): (n):_________ (%):_____________ 
 
 
Ethnicity breakdown (n):______________ (%):___________ 
 
 




Study numbers Eligible for inclusion: ___________ 
 
 
Excluded: __________  
Refused to take part: _________ 
 
 
Randomized to intervention group(s): __________  
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Randomized to control group(s): ____________ 
 
 
Excluded post randomization (for each group; with reasons if relevant): 
__________  
 
Withdrawn (for each group; with reasons if relevant): __________ 
 
 
Lost to follow up (for each group; with reasons): ____________ 
 
 
Included in the analysis (for each group; for each outcome: 
 
 
How often did the intervention take place?  
 
 
How long did the intervention last?  
 
 
If there were follow-up sessions/activities post interventions, what were they and 





 Health education  
 Counseling 
     - Individual 
     - Group 
     - Family 
 Multicomponent Intervention (Check all that apply) 
 Social support/mutual support/peer support groups  
 Consultation/physician advice 
 Pharmacological (Check all that apply) 
     - Buproprion 
     - Clonodine 
     - Nortiptyline 
     - Nicotine Replacement Therapy (NRT) 
          - NRT: patches 
          - NRT: gum 
          - NRT: nasal spray 
          - NRT: inhaler 
          - NRT: lozenges 
          - NRT: Varenicline 
 Self-help material (i.e. brochures, pamphlets, books, videos) 
 Quitline 
 Community outreach 
 Others: ______________________________________________________ 
 
Delivery How was the intervention delivered? (Check all that apply) 
 Face-to-face (i.e. classes, workshops, small groups) 
 Telephone 
 Website 
 Mobile apps  
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 Media (i.e. radio, TV, pamphlet)  
 Others: ___________________________________________________ 
Structure How was the intervention structured? (Check all that apply) 
 One-on-one 
 In groups 
 Smokers-only 
 Nonsmoker-only 
 Smoker and nonsmoker dyads 
 Family as a whole 
 
Frequency How often did the intervention take place?  
 
 
Duration How long did the intervention last?  
 
 
How long was each session? 
 
 
Intensity What was the level of treatment intensity? Consider session length, total amount 
of contact time, and number of sessions.  
 Low (e.g., brief phone call, no clinic visits, passive receipt of materials) 
 Moderate (e.g., one clinic visit, telephone counseling sessions) 




Follow up If there were follow-up sessions/activities post interventions, what were they and 






Was there cultural tailoring to the intervention?  
Yes    No     Unclear  
 
How was the intervention culturally tailored?  
 Tailored to Asian Americans broadly 
 Tailored specifically to Asian American subgroups 










Outcome How was smoking abstinence measured? 
 Self-report 
 Biochemical verification 
     - Saliva cotinine 
     - Breath carbon monoxide 
 Both 
 Other: __________________ 
 
 
What self-reported smoking abstinence outcome was used? 
 Day of (no smoking at time of assessment/interview) 
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 24-hour point prevalence (no smoking in the past 24 hours) 
 7-day point prevalence (no smoking in the past 7 days) 
 1 month continuous abstinence (no smoking in the past 28 days) 
 6 month sustained abstinence (no smoking in the past 6 months) 
 12 month sustained abstinence (no smoking in the past 12 months) 
 5-year sustained abstinence (no smoking in the past 5 years) 
 Other: _________ 
What was the average duration of abstinence (in weeks): ________  
Risk of Bias Selection bias: 











Were intervention conditions known to:  
 No one 
 Participants 
 Providers 
 Data collectors 
 Others 
 





Attrition bias:  





Reporting bias:  
How was smoking abstinence measured? 
 Self-report 
 Biochemical verification 
     - Saliva cotinine 
     - Breath carbon monoxide 
 Both 




4. Data and results  
Odds ratio 
 Intervention (n) Control (n) 
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Quit (n)   
Not Quit (n)   





Timing of outcome 
assessment 
(days/months) 
Intervention group* Comparison group or 




Total (N) Observed 
(n) 
Total (N) 
       
       
       
       
       




Timing of outcome 
assessment 
(days/months) 
Intervention group Comparison group or 










       
       
       
       
       
 
Summary of Data Extraction 
Completed data extraction  Request further details?   Yes    No  
Verified by second coder?   Yes    No  Second coder: _________________________ 
Verification completed on: _________________________ Differences resolved  Yes    No  
Notes:  
 
